Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma
Clinical trial NCT06567600 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06567600
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2027-12-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.